These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6336410)

  • 1. Membrane and chromatography separation techniques for the preparative isolation of uremic toxins.
    Brunner H; Mann H
    Life Support Syst; 1983; 1 Suppl 1():199-206. PubMed ID: 6336410
    [No Abstract]   [Full Text] [Related]  

  • 2. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
    Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale isolation of middle and higher molecular weight uremic toxins.
    Brunner H; Mann H; Essers U; Byrne T
    Artif Organs; 1981; 4 Suppl():41-5. PubMed ID: 7295094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination of conventional and high-performance liquid chromatographic techniques for the isolation of so-called "uraemic toxins".
    Brunner H; Mann H
    J Chromatogr; 1984 Aug; 297():405-16. PubMed ID: 6490772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G; Strecker G; Cueille G; Boudet J; Man NK; Galli A; Agneray J
    Artif Organs; 1981; 4 Suppl():17-21. PubMed ID: 7295087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic toxins.
    Ringoir S; Schoots A; Vanholder R
    Kidney Int Suppl; 1988 Mar; 24():S4-9. PubMed ID: 3283412
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparative isolation of middle molecular weight fractions from the hemofiltrate of patients with chronic uremia.
    Brunner H; Mann H; Essers U; Schultheis R; Byrne T; Heintz R
    Artif Organs; 1978 Nov; 2(4):375-7. PubMed ID: 743009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hydrophobic uremic middle molecules in hemofiltrate of a dialysis patient].
    Konobu K; Matsumoto T; Sawanishi K
    Nihon Jinzo Gakkai Shi; 1988 Feb; 30(2):151-60. PubMed ID: 3386019
    [No Abstract]   [Full Text] [Related]  

  • 10. Separation, isolation and amino acid composition of uremic peptides.
    Shaykh M; Dubin A; Dunea G; Mamdani B; Ahmed S
    Clin Physiol Biochem; 1984; 2(1):1-13. PubMed ID: 6488692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and identification of canine plasma components suspected as uremic toxins.
    Kawamura M; Ohashi F; Nagata Y; Takai N; Motoie H; Nishimura R; Sasaki N; Takeuchi A
    J Vet Med Sci; 1993 Apr; 55(2):265-70. PubMed ID: 8513007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemofiltration-induced serum modifications in the pattern of larger molecules.
    David S; Barani R; Buzio C; Arisi L; Quaretti P
    Adv Exp Med Biol; 1987; 223():281-6. PubMed ID: 3447447
    [No Abstract]   [Full Text] [Related]  

  • 14. Search for peptidic "middle molecules" in uremic sera: isolation and chemical identification of fibrinogen fragments.
    Kaplan B; Cojocaru M; Unsworth E; Knecht A; Martin BM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):141-53. PubMed ID: 14552825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotachophoretic separation of middle molecule peptides in uremic body fluids.
    Zimmerman L; Baldesten A; Bergström J; Fürst P
    Clin Nephrol; 1980 Apr; 13(4):183-8. PubMed ID: 7379369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodology for identification of serum middle molecules.
    Buzio C; Montagna G; Calderini C; Manari A; Migone L
    Artif Organs; 1981; 4 Suppl():22-7. PubMed ID: 7295090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation, isolation, and identification of middle molecules.
    Bergström J; Fürst P; Zimmerman L
    Artif Organs; 1981; 4 Suppl():5-7. PubMed ID: 7295096
    [No Abstract]   [Full Text] [Related]  

  • 18. What remains of the "middle molecule" hypothesis today?
    Brunner H; Mann H
    Contrib Nephrol; 1985; 44():14-39. PubMed ID: 3886282
    [No Abstract]   [Full Text] [Related]  

  • 19. Separation from uremic body fluids and normal urine of Na+, K+-ATPase inhibitor.
    Gallice P; Monti JP; Braguer D; Durand C; Manchon H; Murisasco A; Crevat A
    Adv Exp Med Biol; 1987; 223():215-8. PubMed ID: 2833847
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isolation, structure elucidation and synthesis of a hexapeptide from the hemodialysate of uremic patients].
    Bovermann G; Rautenstrauch H; Seybold G; Jung G
    Hoppe Seylers Z Physiol Chem; 1982 Oct; 363(10):1187-202. PubMed ID: 7141402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.